Bio-Techne Corp

TECH

Company Profile

  • Business description

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

  • Contact

    614 McKinley Place N.E.
    MinneapolisMN55413
    USA

    T: +1 612 379-8854

    https://www.bio-techne.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    3,100

Stocks News & Analysis

stocks

Strong results from cheap ASX share

The market responded favourably to results but shares still underpriced.
stocks

Anthropic’s Claude code security release is not bad news for cyber stocks

We believe cyber vendors will be able to adopt LLM’s for their benefit.
stocks

Earnings losers: TWE, GMG, SUN and more fall on weaker profits

Where companies fell short of market expectations in the third week of earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.3016.50-0.18%
CAC 408,519.2122.040.26%
DAX 4024,986.255.72-0.02%
Dow JONES (US)49,174.50370.440.76%
FTSE 10010,680.594.15-0.04%
HKSE26,590.32491.59-1.82%
NASDAQ22,863.68236.411.04%
Nikkei 22557,321.09495.390.87%
NZX 50 Index13,559.6627.350.20%
S&P 5006,890.0752.320.77%
S&P/ASX 2009,022.3012.10-0.13%
SSE Composite Index4,117.4135.340.87%

Market Movers